23 (Bloomberg) — Peter Tam, president of Vivus Inc., talks about the outlook for the company's Qnexa obesity drug after US Food and Drug Administration advisers voted 20-2 yesterday that the pill's benefits outweigh its risks.
Should the FDA Give Diet Drug Qnexa Another Chance? Posted by Martha Rosenberg on @ 3:17 pm. Article printed from speakeasy: http://blogs.alternet.org/speakeasy. URL to article:
21 (HealthDay News) — The U.S. Food and Drug Administration plans to take a second look at the weight loss pill Qnexa on Wednesday, after initially rejecting it because of concerns about heart problems and possible birth
Qnexa helped patients lose weight * One ingredient tied to birth defects * Uncertain effect on the heart * FDA advisory panel to vote on drug Wednesday afternoon * Vivus shares halted pending vote By Anna Yukhananov
SILVER SPRING, Md. — A previously rejected weight loss pill won an overwhelming endorsement from public health advisers Wednesday, raising hopes that the drug from Vivus Inc. could become the first new anti-obesity